Myomo (FRA:0M61) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0M61 Myomo Inc FRA:0M61
59 GF Score
Price €0.95
GF Value €2.70
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Myomo Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:0M61 vs FOFA, ELUT, PAVM: Short Interest Comparison

For the Medical Devices subindustry, Myomo's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Myomo Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Short Interest distribution charts can be found below:

* The bar in red indicates where Myomo's Short Interest falls into.


FRA:0M61
59GF Score
Myomo Inc FRA:0M61
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Myomo (FRA:0M61) Overvalued in 2026?

Based on GuruFocus' analysis, Myomo stock appears to be undervalued. The current stock price of €0.95 is trading 64.9% below its estimated GF Value™ of €2.70. GuruFocus considers Myomo to be Possible Value Trap.

Key valuation signals for FRA:0M61:

  • Short Interest:
  • GF Value™: €2.70 vs. price of €0.95 (64.9% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the FRA:0M61 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Myomo Business Description

Other Exchanges MYO:USA
Address 45 Blue Sky Drive, Suite 101, Burlington, MA, USA, 01803
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
59GF Score

Get the complete analysis for FRA:0M61

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.95
Price
€2.70
GF Value